Hutch News

Hutch News

Stories tagged 'antibodies'

Engineering vaccine-like protection without a vaccine

CRISPR gene-editing used on antibody-making B cells

May 17, 2019 | By Sabin Russell / Fred Hutch News Service

A Hutch team led by Dr. Justin Taylor shows that B cells, which are crucial components of the immune system, can be genetically engineered to make exactly the antibodies we want. It could lead to a potentially more precise and dependable way to generate protection without vaccines.

View story >


New antibody and unique binding site offer possible paths to malaria prevention

Led by NIH, Fred Hutch researchers, early study holds promise for direct infusion or vaccine design

March 19, 2018 | By Mary Engel / Fred Hutch News Service

Fred Hutch structural biologist Dr. Marie Pancera is seeking clues for designing a malaria vaccine by studying the differences between newly discovered antibodies that bind the same site on the malaria parasite.

View story >


Bringing a leukemia treatment back to life with precision medicine

New research writes latest chapter in one drug's story

June 27, 2017 | by Susan Keown / Fred Hutch News Service

The leukemia drug gemtuzumab ozogamicin (Mylotarg) was pulled from the market seven years after initial approval. Now, new evidence may be bringing it back to life to treat a specific group of patients.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.